LaurieJaneBauerDO

PubMed

• 54 citations
  Comparison of cisternal and lumbar CSF examination in leptomeningeal metastasis
  Lisa R. Rogers, Paul M. Duchesneau, C. Nunez, A. J. Fishleder, James K. Weick
  Neurology. 1992-06-01
• 28 citations
  Phase I Trial of Dipyridamole with 5-Fluorouracil and Folinic Acid
  George Thomas Budd, A. Jayaraj, David C. Grabowski, David J. Adelstein, Laurie Bauer
  Cancer Research. 1990-11-15
• 42 citations
  Induction of cytokine messenger RNA and secretion in alveolar macrophages and blood monocytes from patients with lung cancer receiving granulocyte-macrophage colony-st...
  Mary Jane Thomassen, Muzaffar Ahmad, Barbara P. Barna, J. M. Antal, Herbert P. Wiedemann
  Cancer Research. 1991-02-01

Journal Articles

• Observed characteristics of suicidal hangings: An 11-year retrospective review  
  Dean DE, Kohler LJ, Sterbenz GC, Gillespie PJ, Gonzaga NS, Bauer LJ, et al, Journal of Forensic Sciences, 1/1/2012
• Effect of dipyridamole plus aspirin on hemodialysis graft patency  
  Dixon BS, Beck GJ, Vazquez MA, et al (acknowledgement), New England Journal of Medicine, 1/1/2009
• Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial  
  Dember LM, Beck GJ, Allon M, et al. (acknowledgement), Journal of the American Medical Association, 1/1/2008
• Lung transplantation in the management of patients with lymphangioleiomyomatosis: baseline data from the NHLBI LAM Registry  
  Maurer JR, Ryu J, Beck G, et al. (acknowledgement), The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation, 1/1/2007
• The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment  
  Ryu JH, Moss J, Beck GJ, et al, (acknowledgement), American Journal of Respiratory and Critical Care Medicine, 1/1/2006
• Design of the Dialysis Access Consortium (DAC) Aggrenox prevention of access stenosis trial  
  Dixon BS, Beck GJ, Dember LM, et al. (acknowledgement), Clinical Trials, 1/1/2005
• Effect of dialysis dose and membrane flux in maintenance hemodialysis  
  Eknoyan G, Beck GJ, Cheung AK, et al. (acknowledgement), New England Journal of Medicine, 1/1/2002
• Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial  
  Agodoa LY, Appel L, Bakris GL, et al, (acknowledgement), Journal of the American Medical Association, 1/1/2001
• Design and statistical issues of the hemodialysis (HEMO) study  
  Greene T, Beck GJ, Gassman JJ, Gotch FA, Kusek JW, Levey AS, Levin NW, Schulman G, Eknoyan G, Control Clin Trials, 1/1/2000
• Initial dissection of the lateral fascia reduces the positive margin rate in radical prostatectomy  
  Klein EA, Levin HS, Tuason L, Journal of Urology, 1/1/1996
• Abnormalities signaling of elements in peripheral blood T-cells (PBL-T) from patients with metastatic renal cell cancer: effects of therapy with IL-2 and IFN-alpha  
  Bukowski RM, Olencki T, McLain D, Wang Q, Tuason L, Redovan C, Kle n E, Novick A, Finke J, Journal of Urology, 1/1/1996
• Phase I trial of subcutaneous recombinant macrophage colony-stimulating factor: clinical and immunomodulatory effects  
  Bukowski RM, Budd GT, Gibbons JA, Bauer RJ, Childs A, Antal J, Finke J, Tuason L, Lorenzi V, McLain D, Tubbs R, Edinger M, Thomassen MJ, Journal of Clinical Oncology, 1/1/1994
• Concurrent chemotherapy (CT) and hyperfractionated radiotherapy followed by surgical resection for esophageal carcinoma  
  Adelstein DJ, Rice W, Tefft M, Koka A, Kirby TJ, Tuason LJ, Taylor ME, Van Kirk MA, Proceedings of the American Society of Clinical Oncology, 1/1/1994
• Pharmacokinetics and pharmacodynamics of recombinant interleukin-3 (rhIL-3) following subcutaneous (SQ) administration to patients with refractory malignancies  
  Bukowski RM, Olencki T, McLain D, Tuason L, Budd T, Sandstrom K, Rayman P, Gunn H, Levitt D, Finke J, Blood, 1/1/1994
• Cytokine gene expression and secretion: effects of rhIL-6 in cancer patients  
  Olencki T, Budd GT, Murthy S, Finke J, Herzog P, McLain D, Tubbs R, Tuason L, Edinger M, Levitt D, Bukowski RM, Blood, 1/1/1993
• Clinical and laboratory analysis of patients with deletions of part of chromosome 5q  
  Wos E, Hoeltge G, Tuason L, Lichtin A, Blood, 1/1/1993
• Pelvic washings for cytologic analysis in endometrial adenocarcinoma  
  Kennedy AW, Webster KD, Nunez C, Bauer L, Journal of Reproductive Medicine, 1/1/1993
• Thyroid disease (TD) and prognosis in metastatic renal cell carcinoma  
  Hercbergs A, Prescott J, Bauer L, Proceedings of the American Society of Clinical Oncology, 1/1/1993
• Phase IA/IB trial of rhIL-3 in patients with refractory malignancies: an immunomodulatory cytokine  
  Bhatia A, Olencki T F nke J, Thomassen MJ, McLain D, Sandstrom K, Tuason L, Levitt D, Young D, Bukowski RM, Proceedings of the American Association for Cancer Research, 1/1/1993
• Phase I trial of perioperative cyclophosphamide (CTX) in operable breast cancer  
  Budd G, Hardesty I, Grundfest S, Boyett J, Tuason L, Hermann R, Steiger E, Murthy S, Andresen S, Raaf J, Esselstyn CB, Proceedings of the American Society of Clinical Oncology, 1/1/1993
• Phase IA/IB trial of rhIL-3 in patients with refractory malignancies: Hematologic and immunologic effects  
  Bhatia A, Olencki T, Murthy S, Budd GT, Finke J, Sicca D, Thomassen MJ, Sandstrom SK, Tubbs R, Bauer L, Edinger M, Young D, Resta D, Bukowski RM, Blood, 1/1/1992
• Early continence after radical prostatectomy  
  Klein EA (acknowledgement), Journal of Urology, 1/1/1992
• Treatment of metastatic breast cancer with high-dose chemotherapy followed by autologous bone marrow transplantation (ABMT)  
  Lichtin A, Weick J, Andresen S, Burwell R, Sands K, Murar A, Bauer L, Fishleder A, Green R, Bolwell B, Proceedings of the American Society of Clinical Oncology, 1/1/1991
• Intrathecal baclofen for spasticity in cerebral palsy  
  Albright AL, Cervi A, Singletary J (acknowledgement), Journal of the American Medical Association, 1/1/1991
• Phase I trial of double dose (BID) WR-2721 and carboplatin (CBDCA)  
  Budd GT, Ganapathi R, Gibson V, Bauer L, Adelstein D, Murthy SV, Sergi J, Bukowski RM, Proceedings of the American Society of Clinical Oncology, 1/1/1991
• Join now to see all

Books/Book Chapters

• Biology of Renal Cell Carcinoma 
  Chapter: Cytokine Therapy of Metastatic Renal Cell Carcinoma: The Cleveland Clinic Experience 
  Page 189 - 203Bukowski, R.M., Olencki, T., Peereboom, D., Budd, G.T., Murthy, S., Tubbs, R., Rayman, P., McLain, D., Klein, E., Tuason, L., Finke, J.Editors: R.M. Bukowski, J.H. Finke, E.A. Klein.Springer-Verlag, New York, NY1995
• Immunotherapy of Cancer with Sensitized T Lymphocytes 
  Chapter: Adoptive Immunotherapy Utilizing IL-2 and IL-4 for Expansion of Tumor-Infiltrating Lymphocytes in Renal CelltCarcinoma. 
  Page 123 - 131Rayman, P., Finke, J.H., Olencki, T., Lorenzi, V., Tuason, L., Klein, E., Tubbs, R.R., McLain, D., Bukowski, R.M.Editors: A.E. Chang, S. Shu.Landes Bioscience, Austin, TX1994
• Renal Cell Carcinoma: Immunotherapy and Cellular Biology 
  Chapter: Phenotypic and Functional Analysis of Lymphoid Cells in the Peripheral Blood Tumor of Cancer Patients Treated with Recombinant Interleukin-2 plus Interferon-alpha. 
  Page 273 - 296Budd, G.T., Finke, J.H., Tubbs, R.R., Edinger, M., Stanley, J., Murthy, S.R., Sergi, J.S., Medendorp, S.V., Gibson, V., Bauer, L., Bukowski, R.M.Editors: E.A. Klein, R.M. Bukowski, J.H. Finke.Marcel Dekker, Inc., New York, NY1993
• Renal Cell Carcinoma: Immunotherapy and Cellular Biology 
  Chapter: Tumor-Infiltrating Lymphocytes in Metastatic Renal Cell Carcinoma. 
  Page 127 - 137Bukowski, R.M., Murthy, S.R., Klein, E.A., Bauer, L., Tubbs, R.R., Budd, G.T., Sergi, J.S., Gibson, V., Rayman, P., Stanley, J., Finke, J.H.Editors: E.A. Klein, R.M. Bukowski, J.H. Finke.Marcel Dekker, Inc., New York, NY1993
• Join now to see all

Abstracts/Posters

• Optimizing Molecular Genetic Test Utilization Through Test Review and Intervention.
  Bauer LJ, Riley J, Lacbawan L, American College of Medical Genetics and Genomics 2015 Annual Clinical Genetics Meeting, Salt Lake City, UT, 1/1/2015
• Evaluation of thrombotic risk in lupus anticoagulant positive patients; effect of antiphospholipid antibodies.
  Rogers H, Ruiz Quintero S, Bauer L, Timur A, Kottke-Marchant K, International Society for Laboratory Hematology 2015, the XXVIIIth International Symposium on Technological Innovations in Laboratory Hematology, Chicago, IL, 1/1/2015
• Electronic Medical Record (EMR) Order Set Design for Therapeutic Apheresis Practice to Capture Apheresis Processes: A Multidisciplinary Team Strategy for "Meaningful U...
  Bauer LJ, Reeves HM, Lavallo E, Hendrix D, Hilliard BA, Downes KA, American Society for Apheresis, San Francisco, CA, 1/1/2014
• The Impact of Tissue Thickness on the Interpretation of HER-2/neu Immunohistochemical Staining by Ventana Image Analysis Cystem(VIAS) and a Community Pathologist.
  Barrett HL, Bauer LJ, Criss K, Deeken AH, Summa Health System, Summa Akron City and St. Thomas Hospitals Twenty-First Annual Postgraduate Day, Akron, OH, 1/1/2013
• Gene Survey Finds More Autosomal Recessive Diseases Exist with No Common Mutations than Diseases Selected for by Increased Carrier Fitness or Mutation Hotspots.
  Bauer L, Lebo RV, Summa Health System, Summa Akron City and St. Thomas Hospitals Twentieth Annual Postgraduate Day, Akron, OH, 1/1/2012
• Observed Characteristics of Suicidal Hangings: An Eleven-Year Retrospective Review.
  Gonzaga N, Dean DE, Kohler LJ, Sterbenz GC, Gillespie PJ, Bauer LJ, Looman K, Owens O, Summa Health System, Summa Akron City and St. Thomas Hospitals Nineteenth Annual Postgraduate Day, Akron, OH, 1/1/2011
• Implementing the Medical Dictionary for Regulatory Activities (MedDRA) in the Cohort Phase of the African American Study of Kidney Disease and Hypertension (AASK).
  Gassman J, Tuason L, Brittain K, Litowitz H, Middleton J, Wiggins K, and the AASK Group, Society for Clinical Trials 25th Annual Meeting, London, United Kingdom, 1/1/2003
• The clinical outcome of patients with ovarian clear cell adenocarcinoma.
  Emery J, Kennedy A, Biscotti C, Markman M, Tuason L, Society of Gynecologic Oncologists, Phoenix, AZ, 1/1/1997
• Clinical characteristics of patients with 11q23 chromosome abnormality.
  Andrish S, Hoeltge G, Tuason L, Lichtin A, American Society of Hematology, Orlando, FL, 1/1/1996
• Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) on routine cervical cytology screening.
  Salmieri SS, Kennedy AW, Wirth SL, Biscotti CV, Tuason LJ, Society of Gynecologic Oncologists, New Orleans, LA, 1/1/1996
• Clinical characteristics of patients with 20q-chromosome deletion.
  Tandon R, Tuason L, Hoeltge G, Lichtin A, American Society of Hematology, Seattle, WA, 1/1/1995
• Effect of tamoxifen and trans-retinoic-acid on serum insulin-like growth factor-I in patients with advanced breast cancer.
  Homayoun P, Gupta MK, Van Lente F, Tuason LJ, Sandstrom K, Budd T, 17th Annual San Antonio Breast Cancer Symposium, San Antonio, TX, 1/1/1994
• Randomized phase II trial of carboplatin vs. carboplatin + amifostine in advanced malignancy.
  Budd GT, Murthy S, Bukowski RM, Adelstein D, Lorenzi V, McLain D, Tuason L, Greene T, Graden D, Reynolds R, 8th NCI-EORTC Symposium on New Drugs in Cancer Therapy, Amsterdam, Netherlands, 1/1/1994
• Empiric prednisone therapylfor pulmonary toxicity after high-dose carmustine (BCNU).
  Kalaycioglu M, Kavuru M, Tuason.L, Bolwell B, American Society of Clinical Onco ogy, Dallas, TX, 1/1/1994
• Modulation of T-lymphocytes by interleukin-3 (rIL-3) in vivo: Results of a phase I trial of patients with malignancy.
  Bukowski RM, Olencki T, Murthy S, Tubbs R, McLain D, Tuason L, Sandstrom K, Finke J, American Association for Cancer Research, San Francisco, CA, 1/1/1994
• Antitumor effects of IL-6 alone and in combination with IL-2 and/or cyclophosphamide in the weakly immunogenic murine RENCA tumor.
  Olencki T, Rayman P, Finke J, Tuason L, Greene T, Meyers L, Levitt D, Bukowski RM, American Association for Cancer Research, San Francisco, CA, 1/1/1994
• Immunoregulatory and hematopoietic effects of interleukin-6 (rhIL-6) in cancer patient.
  Olencki T, Budd GT, Murthy S, Finke J, Herzog P, McLain D, Tubbs R, Tuason L, Edinger M, Levitt D, Bukowski RM, American Society of Clinical Oncology, Orlando, FL, 1/1/1993
• Major ABO incompatible allogeneic bone marrow transplantation after treatment with Busulfan and Cyclophosphamide.
  Kalaycioglu M, Lichtin A, Andresen S, Fishleder A, Tuason L, Copelan E, Bolwell B, International Society of Experimental Hematology, Rotterdam, Netherlands, 1/1/1993
• Histologic correlates of progression free interval and survival in ovarian clear cell adenocarcinoma.
  Kennedy AW, Biscotti CV, Tuason LJ, Thirteenth Annual Research Day at the Cleveland Clinic, Cleveland, OH, 1/1/1993
• Clinical and laboratory analysis of patients with deletions of part of chromosome 5q.
  Wos E, Hoeltge G, Tuason L, Lichtin A, Thirteenth Annual Research Day at the Cleveland Clinic, Cleveland, OH, 1/1/1993
• Phase IA/IB trial of rhIL-6 in patients with refractory malignancies: an immunomodulatory cytokine.
  Olencki T, Budd GT, Murthy S, Finke J, Herzog P, McLain D, Tubbs R, Tuason L, Edinger M, Levitt D, Bukowski RM, Society for Biological Therapy Annual Meeting, Nashville, TN, 1/1/1993
• Cytokine gene expression and secretion: Effects of rhIL-6 in cancer patients.
  Olencki T, Budd GT, Murthy S, Finke J, Herzog P, McLain D, Tubbs R, Tuason L, Edinger M, Levitt D, Bukowski RM, Thirteenth Annual Research Day at the Cleveland Clinic, Cleveland, OH, 1/1/1993
• Phase IA/IB trial of rhIL-6 in patients with refractory malignancy: Hematologic and immunologic effects.
  Olencki T, Budd GT, Murthy S, Finke J, Herzog P, Tubbs R, Bauer L, Edinger M, Levitt D, Bukowski RM, American Society of Hematology, Anaheim, CA, 1/1/1992
• A randomized controlled trial of preoperative radiation therapy (RT) vs. concurrent chemoradiotherapy (CRT) for resectable squamous cell head and neck cancer (SCHNC): ...
  Adelstein DJ, Lavertu P, Saxton JP, Van Kirk MA, Johnston D, Bauer L, Wood BG, Eliachar I, Tucker HM, Twelfth Annual Research Day at the Cleveland Clinic, Cleveland, OH, 1/1/1992
• Thyroid disease and survival in metastatic renal cell carcinoma.
  Prescott JS, Hercbergs A, Bauer LJ, Fine R, Tefft M, Twelfth Annual Research Day at the Cleveland Clinic, Cleveland, OH, 1/1/1992
• Join now to see all

Lectures

• Word processor friendly PROC MEANS type SAS output using the SAS macro facility. 
  Cleveland, OH - 1/1/1995
• Word processor friendly SAS output using the SAS macro facility. 
  Orlando, FL - 1/1/1995
• Management of stage D1 adenocarcinoma of the prostate: Role for early hormone therapy. 
  Washington, DC - 1/1/1992
• A prostate cancer screening day: public response and clinical findings. 
  Cincinnati, OH - 1/1/1990
• Join now to see all

Other

• Pedigree analysis: a team-based learning activity. 
  Thatcher J, Canfield P, Bauer L, Griffith BN, MedEdPORTAL Publications
  https://doi.org/10.15766/mep_2374-8265.10557
  1/1/2017